NM_003978.5:c.657A>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_003978.5(PSTPIP1):​c.657A>C​(p.Gln219His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000399 in 1,612,700 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q219Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

PSTPIP1
NM_003978.5 missense

Scores

2
8
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.252

Publications

3 publications found
Variant links:
Genes affected
PSTPIP1 (HGNC:9580): (proline-serine-threonine phosphatase interacting protein 1) This gene encodes a cytoskeletal protein that is highly expressed in hemopoietic tissues. This protein functions via its interaction with several different proteins involved in cytoskeletal organization and inflammatory processes. It binds to the cytoplasmic tail of CD2, an effector of T cell activation and adhesion, downregulating CD2-triggered adhesion. It binds PEST-type protein tyrosine phosphatases (PTP) and directs them to c-Abl kinase to mediate c-Abl dephosphorylation, thereby, regulating c-Abl activity. It also interacts with pyrin, which is found in association with the cytoskeleton in myeloid/monocytic cells and modulates immunoregulatory functions. Mutations in this gene are associated with PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. It is hypothesized that the disease-causing mutations compromise physiologic signaling necessary for the maintenance of a proper inflammatory response. [provided by RefSeq, Mar 2016]
PSTPIP1 Gene-Disease associations (from GenCC):
  • pyogenic arthritis-pyoderma gangrenosum-acne syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • autoinflammatory syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009078503).
BP6
Variant 15-77031194-A-C is Benign according to our data. Variant chr15-77031194-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 245667.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 248 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSTPIP1NM_003978.5 linkc.657A>C p.Gln219His missense_variant Exon 10 of 15 ENST00000558012.6 NP_003969.2 O43586-1A0A0S2Z5P3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSTPIP1ENST00000558012.6 linkc.657A>C p.Gln219His missense_variant Exon 10 of 15 1 NM_003978.5 ENSP00000452746.1 O43586-1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
152214
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00535
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000593
AC:
147
AN:
247912
AF XY:
0.000431
show subpopulations
Gnomad AFR exome
AF:
0.00608
Gnomad AMR exome
AF:
0.000406
Gnomad ASJ exome
AF:
0.000499
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000240
Gnomad OTH exome
AF:
0.000662
GnomAD4 exome
AF:
0.000271
AC:
396
AN:
1460368
Hom.:
0
Cov.:
30
AF XY:
0.000259
AC XY:
188
AN XY:
726362
show subpopulations
African (AFR)
AF:
0.00621
AC:
208
AN:
33468
American (AMR)
AF:
0.000537
AC:
24
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26118
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52528
Middle Eastern (MID)
AF:
0.00417
AC:
24
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000828
AC:
92
AN:
1111522
Other (OTH)
AF:
0.000564
AC:
34
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00163
AC:
248
AN:
152332
Hom.:
1
Cov.:
33
AF XY:
0.00165
AC XY:
123
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00534
AC:
222
AN:
41582
American (AMR)
AF:
0.000850
AC:
13
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000609
Hom.:
1
Bravo
AF:
0.00195
ESP6500AA
AF:
0.00438
AC:
18
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000702
AC:
85
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyogenic arthritis-pyoderma gangrenosum-acne syndrome Benign:3
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 05, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:1
Jun 25, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PSTPIP1: BP4, BS1 -

Autoinflammatory syndrome Benign:1
Apr 27, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.83
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.48
T;.;.;T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.57
D
LIST_S2
Uncertain
0.95
D;D;D;D
MetaRNN
Benign
0.0091
T;T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Pathogenic
3.0
M;.;M;.
PhyloP100
0.25
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-4.0
D;D;D;D
REVEL
Uncertain
0.29
Sift
Uncertain
0.014
D;D;D;D
Sift4G
Uncertain
0.044
D;D;D;D
Polyphen
1.0
D;.;D;.
Vest4
0.78
MutPred
0.49
Loss of catalytic residue at Q219 (P = 0.2667);Loss of catalytic residue at Q219 (P = 0.2667);Loss of catalytic residue at Q219 (P = 0.2667);.;
MVP
0.56
MPC
0.59
ClinPred
0.058
T
GERP RS
-2.6
Varity_R
0.24
gMVP
0.64
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139362350; hg19: chr15-77323535; API